Urologic Oncology: Seminars and Original Investigations
Volume 26, Issue 3 , Pages 260-265, May 2008

Understanding differences between high and low volume hospitals for radical prostatectomy

Department of Urology, Division for Health Services Research, The University of Michigan, Ann Arbor, MI 48109, USA

Received 6 February 2007; received in revised form 28 March 2007; accepted 3 April 2007. published online 14 December 2007.

Abstract 

Objectives

We evaluated the impact of the specialized medical and ancillary services available at low vs. high volume prostatectomy centers on prolonged length of stay (LOS) outcomes after radical prostatectomy.

Methods

Using the Nationwide Inpatient Sample, we identified patients who underwent prostatectomy (n = 9,266) for prostate cancer in 2003 using ICD-9 codes. Hospital characteristics were ascertained using the American Hospital Association file. Differences in health services availability according to hospital prostatectomy volume were estimated using logistic regression. Logistic models were fitted to measure the effect of available health services on a prolonged LOS (>90 percentile for sample was 5 days).

Results

Among patients undergoing radical prostatectomy in 2003, 19.0% and 5.4% of patients had a prolonged LOS at low and high volume hospitals, respectively (unadjusted OR 4.2, 95% CI 2.5–6.9). After adjusting for differences in patients and availability of select health services, those treated at low volume centers were 3.3 times more likely to have a prolonged hospitalization compared with those treated at high volume hospitals (95% CI 1.9–5.6). Adjusting for hospital differences attenuated the volume effect by 14.8%.

Conclusions

There are substantial differences in the health care environment according to radical prostatectomy volume. Generally, high volume hospitals offer a much wider array of health care services specific to both post-prostatectomy and general medical care.

Keywords: Prostate cancer, Outcomes, Volume

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 B.K.H. is supported in part by a grant from the John and Suzanne Munn Endowed Research Fund of the University of Michigan Comprehensive Cancer Center.

PII: S1078-1439(07)00099-3

doi:10.1016/j.urolonc.2007.04.001

Urologic Oncology: Seminars and Original Investigations
Volume 26, Issue 3 , Pages 260-265, May 2008